All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.82 Billion TWD | -23.65% |
| 2022 | 3.7 Billion TWD | 68.49% |
| 2021 | 2.19 Billion TWD | 33.76% |
| 2020 | 1.64 Billion TWD | -7.07% |
| 2019 | 1.76 Billion TWD | -34.23% |
| 2018 | 2.68 Billion TWD | 18.73% |
| 2017 | 2.26 Billion TWD | 9.59% |
| 2016 | 2.06 Billion TWD | -8.5% |
| 2015 | 2.25 Billion TWD | 1.17% |
| 2014 | 2.23 Billion TWD | 19.01% |
| 2013 | 1.87 Billion TWD | 3.89% |
| 2012 | 1.8 Billion TWD | 28.49% |
| 2011 | 1.4 Billion TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 478.39 Million TWD | -8.62% |
| 2024 Q1 | 523.54 Million TWD | -8.71% |
| 2023 Q3 | 688.66 Million TWD | -12.44% |
| 2023 Q2 | 786.47 Million TWD | 1.09% |
| 2023 Q1 | 777.96 Million TWD | -11.71% |
| 2023 FY | 2.82 Billion TWD | -23.65% |
| 2023 Q4 | 573.47 Million TWD | -16.73% |
| 2022 Q1 | 665.64 Million TWD | -1.13% |
| 2022 FY | 3.7 Billion TWD | 68.49% |
| 2022 Q4 | 881.1 Million TWD | -29.15% |
| 2022 Q2 | 911.96 Million TWD | 37.0% |
| 2022 Q3 | 1.24 Billion TWD | 36.37% |
| 2021 Q3 | 548.7 Million TWD | -2.97% |
| 2021 Q4 | 673.25 Million TWD | 22.7% |
| 2021 FY | 2.19 Billion TWD | 33.76% |
| 2021 Q2 | 565.5 Million TWD | 37.98% |
| 2021 Q1 | 409.85 Million TWD | -26.25% |
| 2020 Q3 | 475.29 Million TWD | 19.75% |
| 2020 Q4 | 555.76 Million TWD | 16.93% |
| 2020 Q1 | 214.81 Million TWD | -42.29% |
| 2020 FY | 1.64 Billion TWD | -7.07% |
| 2020 Q2 | 396.9 Million TWD | 84.77% |
| 2019 Q3 | 453.12 Million TWD | -22.94% |
| 2019 Q4 | 372.22 Million TWD | -17.85% |
| 2019 FY | 1.76 Billion TWD | -34.23% |
| 2019 Q1 | 354.35 Million TWD | -24.72% |
| 2019 Q2 | 587.99 Million TWD | 65.94% |
| 2018 Q2 | 755.13 Million TWD | 7.8% |
| 2018 FY | 2.68 Billion TWD | 18.73% |
| 2018 Q4 | 470.68 Million TWD | -38.17% |
| 2018 Q3 | 761.28 Million TWD | 0.81% |
| 2018 Q1 | 700.48 Million TWD | 29.13% |
| 2017 Q3 | 691.9 Million TWD | 22.05% |
| 2017 Q2 | 566.9 Million TWD | 22.61% |
| 2017 Q1 | 462.36 Million TWD | 15.77% |
| 2017 FY | 2.26 Billion TWD | 9.59% |
| 2017 Q4 | 542.47 Million TWD | -21.6% |
| 2016 Q2 | 596.88 Million TWD | 18.31% |
| 2016 Q3 | 564.74 Million TWD | -5.39% |
| 2016 Q4 | 399.39 Million TWD | -29.28% |
| 2016 Q1 | 504.51 Million TWD | -14.26% |
| 2016 FY | 2.06 Billion TWD | -8.5% |
| 2015 FY | 2.25 Billion TWD | 1.17% |
| 2015 Q2 | 602.08 Million TWD | 30.78% |
| 2015 Q4 | 588.45 Million TWD | -2.96% |
| 2015 Q3 | 606.38 Million TWD | 0.71% |
| 2015 Q1 | 460.38 Million TWD | 0.0% |
| 2014 FY | 2.23 Billion TWD | 19.01% |
| 2013 FY | 1.87 Billion TWD | 3.89% |
| 2013 Q1 | 409.24 Million TWD | -33.5% |
| 2012 FY | 1.8 Billion TWD | 28.49% |
| 2012 Q4 | 615.4 Million TWD | 0.0% |
| 2011 FY | 1.4 Billion TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sinon Corporation | 19.11 Billion TWD | 85.211% |
| Taiwan Fertilizer Co., Ltd. | 15.01 Billion TWD | 81.175% |
| CH Biotech R&D Co., Ltd. | 1.51 Billion TWD | -86.594% |